(1)
HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS. Вопр. онкол. 2019, 65 (4), 596-602. https://doi.org/10.37469/0507-3758-2019-65-4-596-602.